We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Pamela Tenaerts, Chief Medical Officer at Medable. Tenaerts talks about how they improve accessibility for patients in the 15-year follow-up period mandated by the FDA for patients in gene therapy trials. Patients often travel from far (even internationally) for treatment, sponsors have to pay for infrastructure costs for maintaining multiple sites, and patients have to deal with parking and logistics issues at hospitals.
Medable’s eCOA software enables patients to use their phones to report on outcomes, stay close to home, and do blood work and imaging in local clinics. The benefits for drug company customers are reduced infrastructure costs, better patient retention, faster data collection, and improved regulatory compliance.
Check out the main topics of discussion for this episode of the Life Sciences Today podcast:
- Tell me about your journey to Medable.
- How do you create value for drug companies?
- How do you measure the value?
- What are 3 things you’d like to achieve in the next 12 months?
Now, without further ado, we’re excited to share with you the next episode of the Life Sciences Today podcast.
Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:
Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.
If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.
Thanks so much for listening!
